Chelation Therapy Reduces Cardiovascular Events for Older Patients with Diabetes.  Chelation treatments reduced cardiovascular events, such as heart attacks, and death in patients with diabetes but not in those who did not have diabetes, according to analyses of data from the National Institutes of Health (NIH)-funded Trial to Assess Chelation Therapy (TACT). However, researchers say more studies are needed before it’s known whether this promising finding leads to a treatment option.

Related posts:

  1. Gene therapy helps patients with hemophilia B An experimental gene therapy technique boosted the production of a vital blood clotting factor in six people with hemophilia B, according to new research supported by the National Institutes of Health. The therapy could give patients a long-term solution for preventing prolonged bleeding episodes and spontaneous bleeding....
  2. Medicare Card, Weight loss does not lower heart disease risk from type 2 diabetes Medicare Card, Weight loss does not lower heart disease risk from type 2 diabetes...
  3. Medicare Card, Couple’s Therapy Appears to Decrease PTSD Symptoms, Improve Relationship Medicare Card, Couple’s Therapy Appears to Decrease PTSD Symptoms, Improve Relationship...
  4. Researchers extend use of gene therapy to treat a soft tissue tumor Researchers extend use of gene therapy to treat a soft tissue tumor...
  5. Funded study shows reduction in death for men with intermediate-grade prostate cancer Short-term hormone therapy given in combination with radiation therapy to men with early-stage prostate cancer increased their chances of living longer compared to treatment with radiation therapy alone, according to a clinical trial supported by the National Cancer Institute (NCI), part of the National Institutes of Health. Benefits of the combined treatment were limited mainly […]...
  6. Medicare Card Replacement, New rheumatoid arthritis drug targets NIH-discovered protein The U.S. Food and Drug Administration recently approved a new oral medication for the treatment of rheumatoid arthritis that represents a new class of drugs for the disease. The drug, tofacitinib (Xeljanz), provides a new treatment option for adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to, or who […]...
  7. Researchers design a light therapy that targets and destroys cancer cells in mice Researchers have designed a light-based therapy that allows the selective destruction of tumor cells in mice without harming surrounding normal tissue. This method of cancer therapy could theoretically work against tumors in humans, such as those of the breast, lung, prostate, as well as cancer cells in the blood such as leukemias, say scientists from […]...
  8. Adverse Cardiovascular Events Reported in Testosterone Trial in Older Men A clinical trial of testosterone treatment in older men, reported June 30 online in the New England Journal of Medicine, has found a higher rate of adverse cardiovascular events, such as heart attacks and elevated blood pressure, in a group of older men receiving testosterone gel compared to those receiving placebo. Due to these events, […]...
  9. Quitting smoking outpace risk of a modest weight gain Quitting smoking outpace risk of a modest weight gain...
  10. Medicare, Aiming for Near-Normal, Blood Sugar Did Not Delay Combined Risk of Diabetic Damage for People With Long-standing Diabetes, NIH-Sponsored Trial Finds In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage, a study has found. The intensive glucose treatment was […]...
  11. Genetic abnormality predicts benefit from treatment for a rare brain tumor A clinical trial has shown that addition of chemotherapy to radiation therapy leads to a near doubling of median survival time in patients with a form of brain tumor (oligodendroglioma) that carries a chromosomal abnormality called the 1p19q co-deletion....
  12. Medicare Card, Sharp rise in diabetic eye disease makes American Diabetes Month ever more important Medicare Card, Sharp rise in diabetic eye disease makes American Diabetes Month ever more important...
  13. Bypass surgery, medications both options to be considered for heart failure patients with coronary artery disease A new study found that coronary artery bypass surgery added to medical therapy for selected chronic heart failure patients offered benefits over medical therapy alone. The combination of the two treatment approaches reduced the combined rate of deaths and heart-related hospital stays by 15 percent, although the total number of deaths between the two groups […]...
  14. Medicare Card, Therapy with bone marrow-derived stem cells does not improve short-term recovery after heart attack Medicare Card, Therapy with bone marrow-derived stem cells does not improve short-term recovery after heart attack...
  15. Clinical trial stopped on combination cholesterol treatment The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, extended-release niacin to statin treatment in people with heart and vascular disease, did not reduce the risk of cardiovascular […]...